Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
Notified -
Globe Newswire8-10-2025, 18:09
Wiztrust awarded 10 G2 Badges for Summer 2025, confirming its leadership across Press Release Distribution and Online Newsroom software categories 29-07-2025, 20:47